.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
McKesson
Julphar
Cantor Fitzgerald
Teva
QuintilesIMS
AstraZeneca
Colorcon
Cipla
Federal Trade Commission

Generated: December 18, 2017

DrugPatentWatch Database Preview

Pravastatin sodium - Generic Drug Details

« Back to Dashboard

What are the generic sources for pravastatin sodium and what is the scope of pravastatin sodium patent protection?

Pravastatin sodium
is the generic ingredient in two branded drugs marketed by Bristol Myers Squibb, Accord Hlthcare, Apotex Inc, Aurobindo Pharma Ltd, Cipla Ltd, Dr Reddys Labs Inc, Glenmark Generics, Lupin Pharms, Mylan, Mylan Pharms Inc, Pliva Hrvatska Doo, Ranbaxy Labs Ltd, Sandoz, Teva, Teva Pharms, Watson Labs, and Zydus Pharms Usa, and is included in eighteen NDAs. Additional information is available in the individual branded drug profile pages.

There are sixteen drug master file entries for pravastatin sodium. Forty-nine suppliers are listed for this compound. There are two tentative approvals for this compound.

Pharmacology for pravastatin sodium

Medical Subject Heading (MeSH) Categories for pravastatin sodium

Tentative approvals for PRAVASTATIN SODIUM

Applicant Application No. Strength Dosage Form
u► Subscribe10MGTABLET;ORAL
u► Subscribe80MGTABLET;ORAL
u► Subscribe40MGTABLET;ORAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pliva Hrvatska DooPRAVASTATIN SODIUMpravastatin sodiumTABLET;ORAL077730-001Nov 21, 2006DISCNNoNo► Subscribe► Subscribe► Subscribe
MylanPRAVASTATIN SODIUMpravastatin sodiumTABLET;ORAL077013-004Dec 28, 2007DISCNNoNo► Subscribe► Subscribe► Subscribe
Cipla LtdPRAVASTATIN SODIUMpravastatin sodiumTABLET;ORAL077904-002Oct 23, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe
Cipla LtdPRAVASTATIN SODIUMpravastatin sodiumTABLET;ORAL077904-004Mar 22, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Watson LabsPRAVASTATIN SODIUMpravastatin sodiumTABLET;ORAL076939-001Dec 28, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Ranbaxy Labs LtdPRAVASTATIN SODIUMpravastatin sodiumTABLET;ORAL076445-002Apr 23, 2007DISCNNoNo► Subscribe► Subscribe► Subscribe
Lupin PharmsPRAVASTATIN SODIUMpravastatin sodiumTABLET;ORAL077917-002Jan 8, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
Apotex IncPRAVASTATIN SODIUMpravastatin sodiumTABLET;ORAL076341-002Oct 23, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe
SandozPRAVASTATIN SODIUMpravastatin sodiumTABLET;ORAL076397-003Oct 23, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe
TevaPRAVASTATIN SODIUMpravastatin sodiumTABLET;ORAL076056-002Apr 24, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: pravastatin sodium

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bristol Myers SquibbPRAVACHOLpravastatin sodiumTABLET;ORAL019898-004Mar 22, 1993► Subscribe► Subscribe
Bristol Myers SquibbPRAVACHOLpravastatin sodiumTABLET;ORAL019898-008Dec 18, 2001► Subscribe► Subscribe
Bristol Myers SquibbPRAVACHOLpravastatin sodiumTABLET;ORAL019898-003Oct 31, 1991► Subscribe► Subscribe
Bristol Myers SquibbPRAVACHOLpravastatin sodiumTABLET;ORAL019898-004Mar 22, 1993► Subscribe► Subscribe
Bristol Myers SquibbPRAVACHOLpravastatin sodiumTABLET;ORAL019898-002Oct 31, 1991► Subscribe► Subscribe
Bristol Myers SquibbPRAVACHOLpravastatin sodiumTABLET;ORAL019898-008Dec 18, 2001► Subscribe► Subscribe
Bristol Myers SquibbPRAVACHOLpravastatin sodiumTABLET;ORAL019898-003Oct 31, 1991► Subscribe► Subscribe
Bristol Myers SquibbPRAVACHOLpravastatin sodiumTABLET;ORAL019898-004Mar 22, 1993► Subscribe► Subscribe
Bristol Myers SquibbPRAVACHOLpravastatin sodiumTABLET;ORAL019898-003Oct 31, 1991► Subscribe► Subscribe
Bristol Myers SquibbPRAVACHOLpravastatin sodiumTABLET;ORAL019898-008Dec 18, 2001► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Colorcon
Mallinckrodt
UBS
McKinsey
Citi
Covington
Fuji
Boehringer Ingelheim
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot